Prevention and treatment of acute renal failure in sepsis

被引:63
作者
De Vriese, AS [1 ]
机构
[1] Acad Hosp St Jan, Renal Unit, B-8000 Brugge, Belgium
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷 / 03期
关键词
D O I
10.1097/01.ASN.0000055652.37763.F7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:792 / 805
页数:14
相关论文
共 138 条
[1]   CIRCULATING CONCENTRATIONS AND PHYSIOLOGICAL-ROLE OF ATRIAL-NATRIURETIC-PEPTIDE DURING ENDOTOXIC-SHOCK IN THE RAT [J].
AIURA, K ;
UEDA, M ;
ENDO, M ;
KITAJIMA, M .
CRITICAL CARE MEDICINE, 1995, 23 (11) :1898-1906
[2]   Anaritide in acute tubular necrosis [J].
Allgren, RL ;
Marbury, TC ;
Rahman, SN ;
Weisberg, LS ;
Fenves, AZ ;
Lafayette, RA ;
Sweet, RM ;
Genter, FC ;
Kurnik, BRC ;
Conger, JD ;
Sayegh, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (12) :828-834
[3]   NON-OLIGURIC ACUTE RENAL-FAILURE [J].
ANDERSON, RJ ;
LINAS, SL ;
BERNS, AS ;
HENRICH, WL ;
MILLER, TR ;
GABOW, PA ;
SCHRIER, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (20) :1134-1138
[4]   Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study [J].
Avontuur, JAM ;
Nolthenius, RPT ;
van Bodegom, JW ;
Bruining, HA .
CRITICAL CARE MEDICINE, 1998, 26 (04) :660-667
[5]   ROLES FOR THROMBOXANE-A-2 AND LEUKOTRIENES IN ENDOTOXIN INDUCED ACUTE-RENAL-FAILURE [J].
BADR, KF ;
KELLEY, VE ;
RENNKE, HG ;
BRENNER, BM .
KIDNEY INTERNATIONAL, 1986, 30 (04) :474-480
[6]   PRODUCTION OF TUMOR NECROSIS FACTOR BY RAT MESANGIAL CELLS IN RESPONSE TO BACTERIAL LIPOPOLYSACCHARIDE [J].
BAUD, L ;
OUDINET, JP ;
BENS, M ;
NOE, L ;
PERALDI, MN ;
RONDEAU, E ;
ETIENNE, J ;
ARDAILLOU, R .
KIDNEY INTERNATIONAL, 1989, 35 (05) :1111-1118
[7]  
Bellomo R, 2000, LANCET, V356, P2139
[8]   The effects of ibuprofen on the physiology and survival of patients with sepsis [J].
Bernard, GR ;
Wheeler, AP ;
Russell, JA ;
Schein, R ;
Summer, WR ;
Steinberg, KP ;
Fulkerson, WJ ;
Wright, PE ;
Christman, BW ;
Dupont, WD ;
Higgins, SB ;
Swindell, BB .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :912-918
[9]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[10]  
BERTANI T, 1989, AM J PATHOL, V134, P419